The research in Epigenetics and tissue transformation at the TR2Lab, directed by Ph.D. Laia Bosch Pressegué is focused on studying epigenetic events in different pathologies and how different interventions can prevent their appearance, improve symptoms or contribute to
their healing.
We are focused on how an epigenetic nutrition intervention can contribute to the improvement of patients with cancer, mental illnesses, obesity, etc. And at a more molecular level, and in deep collaboration with other lines of the research group, our main interest is to elucidate the epigenetic mechanisms involved in tissue repair regeneration and contribute to the design of novel therapies.
Team
Our last happenings
New insights into the molecular mechanism of rhodopsin retinitis pigmentosa from the biochemical and functional characterization of G90V, Y102H and I307N mutations
Article: New insights into the molecular mechanism of rhodopsin retinitis pigmentosa from the biochemical and functional characterization of G90V, Y102H and I307N mutations Authors: María Guadalupe Herrera-Hernández, Neda Razzaghi, Pol Fernandez-Gonzalez, Laia Bosch-Presegué, Guillem Vila-Julià, Juan Jesús Pérez, Pere Garriga. PDF article Abstract: Objectives: Mutations in the photoreceptor protein rhodopsin are known as [...]
Maria Cristina Martin joins TR2Lab
Proud to incorporate Maria Cristina Martín as a new researcher of the TR2Lab. Welcome, Maria Cristina Martin, who joins the research line in Applied Epigenetics of the TR2Lab. Maria Cristina Martin is also a technician in Biosciences Laboratories in the Faculty of Science and Technology at the University of [...]
Successful third Seminar of the ACCESSIBLE SCIENCE program
On May 5th was developed the third seminar session of the ACCESSIBLE SCIENCE program: New scientific advances to bring to high school classrooms Success in the third seminar of the ACCESSIBLE SCIENCE program conducted by Ph. Elisabet Dachs focused on what the gene therapy using CRISPR offers. Support materials on [...]
